Clik here to view.
Urinary device startup Vesiflo raises $2.4m, looks to bring in $7m
Medical device startup Vesiflo raised $2.4 million in a new round of equity financing to support its iFlow device designed to treat women with impaired detrusor contractility. Funds raised came from 26...
View ArticleClik here to view.
Micro Medical Solutions wins CE Mark for MicroStent BTK vascular stent
Microvascular interventional device dev Micro Medical Solutions said today it won CE Mark approval in the European Union for its MicroStent vascular stent designed for treating patients with peripheral...
View ArticleClik here to view.
Mexico proposes changes to medical device regulations in 2018
By Stewart Eisenhart, Emergo Group Mexican regulators are in the early stages of revising various elements of the country’s sanitary registration process for medical devices, including classification,...
View ArticleClik here to view.
TransEnterix touts French debut for Senhance robot-assisted surgery device
TransEnterix (NYSE:TRXC) yesterday touted the 1st clinical use in France of its Senhance robot-assisted surgery platform. The 1st French case, performed by Dr. Celine Chauleur of CHU Saint-Ètienne, was...
View ArticleClik here to view.
Hologic to buy Cynosure in $1.65B deal
Hologic (NSDQ:HOLX) said today that it landed a deal to acquire Cynosure Inc. (NSDQ:CYNO) and its portfolio of medical aesthetics products for $1.65 billion. Marlborough, Mass.-based Hologic offered...
View ArticleClik here to view.
Titan Pharmaceutical’s match-sized implant fights back against opioid addiction
The ongoing opioid crisis in the U.S. is harrowing – 91 Americans die every day from an opioid overdose, according to the Centers for Disease Control & Prevention. Companies are searching for...
View ArticleClik here to view.
Pixium logs German reimbursement win for Iris II ‘bionic eye’
Pixium Vision (EPA:PIX) said today that its Iris II ‘bionic eye’ won NUB 1 reimbursement status from the German Institute for the Hospital Remuneration System. The company’s epi-retinal implant has 150...
View ArticleClik here to view.
S&P: Medtech outlook stable, even after downgrades
[Image from Christopher Burns on Unsplash]The outlook for investment-grade medical device companies remains stable even after a 3-year streak of 9 consecutive downgrades, according to a new report from...
View ArticleClik here to view.
These computers can identify diseases in your fecal matter
A cluster of Escherichia coli (E.coli) bacteria magnified 10,000 times. [Photo from Wikipedia]San Diego–area researchers have successfully trained computers to recognize whether microbiomes in the gut...
View ArticleClik here to view.
Tiny magnetic implant delivers drug locally
Researchers from the University of British Columbia have developed a magnetic drug implant that measures just 6 millimeters in diameter and can deliver a drug locally to a targeted tissue. The team’s...
View ArticleClik here to view.
Report: AdvaMed all-in on medical device tax repeal
Including language repealing the medical device tax in an upcoming reconciliation bill is reportedly the Advanced Medical Technology Assn.’s #1 priority, even as Republicans on Capitol Hill disagree on...
View ArticleClik here to view.
Are clinical vendor audits important?
In today’s business environment, it’s important to have reliable partners who can help you achieve your business goals and objectives. In clinical research, this is especially true. One proactive way...
View ArticleClik here to view.
Ex-Medtronic CEO George: Trump’s anti-trade talk risks ‘crony capitalism’
If the administration acts on Donald Trump’s protectionist campaign rhetoric, it could cripple the U.S. economy and lead to “crony capitalism,” former Medtronic (NYSE:MDT) CEO Bill George said this...
View ArticleClik here to view.
Medical device’s biggest players doled out $895m to docs in 2015
The 25 largest medical device companies paid out a collective $894.6 million in general and research fees to doctors in 2015, according to data from the Centers for Medicare & Medicaid Services...
View ArticleClik here to view.
Valeant, Ackman agree to split costs in shareholders class action
Valeant Pharmaceuticals (NYSE:VRX, TSE:VRX) and William Ackman’s hedge fund Pershing Square Capital Management reportedly agreed to split litigation costs in a class action lawsuit brought on by...
View ArticleClik here to view.
MassDevice.com +5 | The top 5 medtech stories for February 14, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s...
View ArticleClik here to view.
Actelion reports income, revenue growth in FY2016
(Reuters) – Swiss drugmaker Actelion‘s 2016 core net income rose 27 percent on accelerating sales of its newer medicines to treat deadly pulmonary arterial hypertension (PAH), it said on Tuesday. Core...
View ArticleClik here to view.
Abbott touts association between monitoring and improved glucose control
Abbott (NYSE:ABT) touted results today from real-world use data for its FreeStyle Libre blood glucose monitoring system. The data showed that people using its FreeStyle Libre system to monitor their...
View ArticleClik here to view.
ICU Medical touts dosing errors study
ICU Medical (NSDQ:ICUI) said today that a multi-hospital study showed improvements in potentially catastrophic dosing errors and drug library compliance when its Plum infusion pumps and Hospira...
View ArticleClik here to view.
Smith & Nephew, Arthrex settle 12-year suture anchors spat
Smith & Nephew (NYSE:SNN) and Arthrex this week buried the hatchet on a 12-year-old dispute over patents covering suture anchors used in joint repair surgeries. Details on the settlement, which...
View Article
